Advertisement

Topics

Single Dose Study of BMS-820836

2014-08-27 03:19:50 | BioPortfolio

Summary

The purpose of this study is to determine the safety and tolerability of BMS-820836 after single doses

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Conditions

Depression

Intervention

BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, Placebo, BMS-820836, BMS-820836

Location

Local Institution
Toronto
Ontario
Canada
M5V 2T3

Status

Completed

Source

Bristol-Myers Squibb

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:19:50-0400

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Multiple-Ascending Dose Study

The purpose of this study is to determine the safety and tolerability of BMS-820836 after multiple doses

PubMed Articles [0 Results]

None

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "Single Dose Study of BMS-820836"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Searches Linking to this Trial